Berenberg Bank Lowers Oxford Nanopore Technologies (LON:ONT) Price Target to GBX 200

Oxford Nanopore Technologies (LON:ONT) had its price objective cut by equities researchers at Berenberg Bank from GBX 220 to GBX 200 in a note issued to investors on Wednesday,Digital Look reports. The brokerage currently has a “buy” rating on the stock. Berenberg Bank’s price objective would suggest a potential upside of 52.67% from the stock’s current price.

A number of other research firms have also issued reports on ONT. Peel Hunt reiterated a “hold” rating and issued a GBX 153 target price on shares of Oxford Nanopore Technologies in a report on Monday, July 13th. Royal Bank Of Canada restated an “outperform” rating and set a GBX 225 price target on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. Finally, Citigroup cut Oxford Nanopore Technologies to a “buy” rating in a research note on Monday, July 20th. Four analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of GBX 200.75.

Oxford Nanopore Technologies Price Performance

Oxford Nanopore Technologies stock opened at GBX 131 on Wednesday. The firm has a market cap of £1.28 billion, a PE ratio of -8.68 and a beta of 0.91. Oxford Nanopore Technologies has a 52-week low of GBX 95.61 and a 52-week high of GBX 215.60. The company has a quick ratio of 6.01, a current ratio of 3.56 and a debt-to-equity ratio of 8.96. The company’s 50 day moving average is GBX 118.16 and its two-hundred day moving average is GBX 122.69.

Oxford Nanopore Technologies (LON:ONT) last issued its quarterly earnings results on Wednesday, August 19th. The company reported GBX (4.90) EPS for the quarter. Oxford Nanopore Technologies had a negative net margin of 64.85% and a negative return on equity of 29.43%.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.